Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus

Protease proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of LDL cholesterol clearance and has been associated with cardiovascular risk. PCSK9 inhibitors increase in vivo circulating endothelial progenitor cells (EPCs), a subtype of immature cells involved in ongoing endothelial...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Tripaldi, Romina, Lanuti, Paola, Simeone, Paola Giustina, Liani, Rossella, Bologna, Giuseppina, Ciotti, Sonia, Simeone, Pasquale, Di Castelnuovo, Augusto, Marchisio, Marco, Cipollone, Francesco, Santilli, Francesca
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102605/
https://ncbi.nlm.nih.gov/pubmed/33958634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-88941-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller